Literature DB >> 35821921

Local Recurrence of Soft Tissue Sarcoma Revisited: Is there a Role for "Selective" Radiation?

Nathan E Saxby1, Qiang An1, Benjamin J Miller1.   

Abstract

Background: Radiation therapy (RT) is often utilized in cases of high-grade soft tissue sarcoma (STS), but there remain situations where treatment is with surgical excision alone. Our goals were to determine (1) the local recurrence (LR) rate with and without perioperative RT and (2) associations between local recurrence, patient, tumor, and treatment variables.
Methods: We performed a retrospective review of 165 consecutive STS patients. A Cox proportional hazards model was used to investigate variables associated with local recurrence.
Results: LR occurred in 15/78 (19%) without RT, 4/29 (14%) with postoperative RT, and 0/58 with preoperative RT (p=0.002). We found increased rates of local recurrence at 24 months for myxofibrosarcoma (p=0.001) and no-RT (p=0.003). Myxofibrosarcoma accounted for 33 (20%) of the study patients and 12 (63%) of the local recurrences.
Conclusion: The LR rate in patients treated with surgery alone was disproportionately attributable to myxofibrosarcoma (11/23 cases, 48%). Other subtypes demonstrated a lower rate of LR in the absence of RT (4/55 cases, 7%), and no LR occurred when final margins were >2 mm. In certain circumstances treatment with a negative margin surgical resection followed by close observation is justifiable. RT is effective and should continue to be considered routinely in myxofibrosarcoma or when surgical margins are inadequate. Level of Evidence: III.
Copyright © The Iowa Orthopaedic Journal 2022.

Entities:  

Keywords:  local recurrence; radiation therapy; soft tissue sarcoma

Mesh:

Year:  2022        PMID: 35821921      PMCID: PMC9210402     

Source DB:  PubMed          Journal:  Iowa Orthop J        ISSN: 1541-5457


  24 in total

1.  Myxofibrosarcoma: prognostic factors and survival in a series of patients treated at a single institution.

Authors:  Roberta Sanfilippo; Rosalba Miceli; Federica Grosso; Marco Fiore; Elisa Puma; Elisabetta Pennacchioli; Marta Barisella; Claudia Sangalli; Luigi Mariani; Paolo G Casali; Alessandro Gronchi
Journal:  Ann Surg Oncol       Date:  2010-09-28       Impact factor: 5.344

2.  Predictors and clinical significance of local recurrence in extremity soft tissue sarcoma.

Authors:  Vignesh K Alamanda; Samuel N Crosby; Kristin R Archer; Yanna Song; Herbert S Schwartz; Ginger E Holt
Journal:  Acta Oncol       Date:  2012-08-09       Impact factor: 4.089

3.  The enigma of myxofibrosarcoma of the extremity.

Authors:  Robert W Mutter; Samuel Singer; Zhigang Zhang; Murray F Brennan; Kaled M Alektiar
Journal:  Cancer       Date:  2011-06-29       Impact factor: 6.860

4.  Prognostic factors and outcomes of patients with myxofibrosarcoma.

Authors:  G Petur Nielsen; John T Mullen; Nicole J Look Hong; Francis J Hornicek; Kevin A Raskin; Sam S Yoon; Jackie Szymonifka; Beow Yeap; Yen-Lin Chen; Thomas F DeLaney
Journal:  Ann Surg Oncol       Date:  2012-08-14       Impact factor: 5.344

5.  Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Margaret von Mehren; R Lor Randall; Robert S Benjamin; Sarah Boles; Marilyn M Bui; Kristen N Ganjoo; Suzanne George; Ricardo J Gonzalez; Martin J Heslin; John M Kane; Vicki Keedy; Edward Kim; Henry Koon; Joel Mayerson; Martin McCarter; Sean V McGarry; Christian Meyer; Zachary S Morris; Richard J O'Donnell; Alberto S Pappo; I Benjamin Paz; Ivy A Petersen; John D Pfeifer; Richard F Riedel; Bernice Ruo; Scott Schuetze; William D Tap; Jeffrey D Wayne; Mary Anne Bergman; Jillian L Scavone
Journal:  J Natl Compr Canc Netw       Date:  2018-05       Impact factor: 11.908

6.  Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial.

Authors:  Brian O'Sullivan; Aileen M Davis; Robert Turcotte; Robert Bell; Charles Catton; Pierre Chabot; Jay Wunder; Rita Kandel; Karen Goddard; Anna Sadura; Joseph Pater; Benny Zee
Journal:  Lancet       Date:  2002-06-29       Impact factor: 79.321

7.  MRI and histological evaluation of the infiltrative growth pattern of myxofibrosarcoma.

Authors:  Mitsunori Kaya; Takuro Wada; Satoshi Nagoya; Mikito Sasaki; Tadaki Matsumura; Takehiko Yamaguchi; Tadashi Hasegawa; Toshihiko Yamashita
Journal:  Skeletal Radiol       Date:  2008-07-16       Impact factor: 2.199

8.  Analysis of Margin Classification Systems for Assessing the Risk of Local Recurrence After Soft Tissue Sarcoma Resection.

Authors:  Kenneth R Gundle; Lisa Kafchinski; Sanjay Gupta; Anthony M Griffin; Brendan C Dickson; Peter W Chung; Charles N Catton; Brian O'Sullivan; Jay S Wunder; Peter C Ferguson
Journal:  J Clin Oncol       Date:  2018-01-18       Impact factor: 44.544

Review 9.  Multidisciplinary treatment of soft tissue sarcomas: An update.

Authors:  Jorge Gómez; Panagiotis Tsagozis
Journal:  World J Clin Oncol       Date:  2020-04-24

10.  High Recurrence Rate of Myxofibrosarcoma: The Effect of Radiotherapy Is Not Clear.

Authors:  Hjalmar Teurneau; Jacob Engellau; Iman Ghanei; Fredrik Vult von Steyern; Emelie Styring
Journal:  Sarcoma       Date:  2019-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.